GoingPublic Case Study on BIONCaRT

In a recent article, goingpublic.de highlights BIONCaRT, our advancements in regenerative medicine, and our innovative cell therapy approach for the treatment of cartilage defects.

https://www.goingpublic.de/life-sciences/case-study-bioncart-stammzellen-fuer-die-regeneration-geschaedigter-gelenke/